AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
πΈπ³
NEPAFENAC in Senegal
7 products registered with ARP β 7 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| NEPAFEN collyre / 1 mg | 756 | SHAIGAN PHARMACEUTICALS | active | β |
| OPHTALGYLE collyre / FL/5ml | UNKNOWN-450703c1 | β | active | β |
| OPHTAGYLE solution ophtalmique / FL/5ml | UNKNOWN-7f214b52 | β | active | β |
| OPHTALGYLE collyre / FL/5ml | UNKNOWN-81b05288 | β | active | β |
| OPHTAGYLE collyre / 1 mg / ml | UNKNOWN-36374610 | INDOLANDS | active | β |
| OPHTAGYLE solution ophtalmique / FL/5ml | UNKNOWN-6b335f36 | β | active | β |
| OPHTAGYLE collyre / 1 mg / ml | UNKNOWN-d5630a7d | INDOLANDS | active | β |
NEPAFENAC β ARP Registration Details
ARP (Senegal) has 7 registered products containing NEPAFENAC, of which 7 are currently active. Data is sourced directly from the official ARP drug register and refreshed daily.
Track NEPAFENAC registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.